# Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy

> **NCT03603080** · PHASE4 · TERMINATED · sponsor: **Hartford Hospital** · enrollment: 12 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Administration of weight loss drug (Metformin or Topiramate)

## Key facts

- **NCT ID:** NCT03603080
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Difficulty with enrollment and then Covid pandemic
- **Last updated:** 2023-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03603080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03603080, "Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03603080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*